The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery

Figures & data

Table 1 Adverse reactions with Omidria™

Eye irritation (1%–10%)

Posterior capsular opacification (1%–10%)

Increased intraocular pressure (1%–10%)

Anterior chamber inflammation (24%)